Tuesday, June 7, 2016

Valeant Reports a 1st-Quarter Loss and Cuts Its Forecast by KATIE THOMAS


By KATIE THOMAS

Valeant, the pharmaceuticals company facing questions about its business and accounting practices, said it lost nearly $374 million in the first quarter.

Published: June 8, 2016 at 12:00AM

from NYT Business Day http://ift.tt/1PDRkw8



from WordPress http://ift.tt/215pycD
via Hadi Aboukhater
Posted by at
Labels: , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)